These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3354257)

  • 1. Influenza virus ISCOMs: biochemical characterization.
    Sundquist B; Lövgren K; Höglund S; Morein B
    Vaccine; 1988 Feb; 6(1):44-8. PubMed ID: 3354257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza virus ISCOMs: antibody response in animals.
    Sundquist B; Lövgren K; Morein B
    Vaccine; 1988 Feb; 6(1):49-53. PubMed ID: 3354258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.
    Morein B; Sundquist B; Höglund S; Dalsgaard K; Osterhaus A
    Nature; 1984 Mar 29-Apr 4; 308(5958):457-60. PubMed ID: 6709052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation of polymeric glycoprotein complexes of enveloped viruses using the Quill A glycoside and a study of their immunogenic activity].
    Berezin VE; Zaĭdes VE; Grigor'ev VB; Klimenko SM; Zhdanov VM
    Vopr Virusol; 1987; 32(3):312-7. PubMed ID: 2823481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine leukaemia virus ISCOMs: biochemical characterization.
    Merza MS; Linné T; Höglund S; Portetelle D; Burny A; Morein B
    Vaccine; 1989 Feb; 7(1):22-8. PubMed ID: 2541575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quaternary structure of the immunostimulating complex (iscom).
    Ozel M; Höglund S; Gelderblom HR; Morein B
    J Ultrastruct Mol Struct Res; 1989 Dec; 102(3):240-8. PubMed ID: 2634709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation and characterization of FeLV ISCOMs.
    Akerblom L; Strömstedt K; Hoglund S; Osterhaus A; Morein B
    Vaccine; 1989 Apr; 7(2):142-6. PubMed ID: 2750272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of herpes simplex virus type-1-immunostimulating complexes (ISCMOs): a multi-glycoprotein structure.
    Erturk M; Jennings R; Phillpotts RJ; Potter CW
    Vaccine; 1991 Sep; 9(9):668-74. PubMed ID: 1659055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Iscom (Immuno Stimulating Complex)-vaccine of equine influenza virus--transmission electron microscopic investigation and literature review].
    Brügmann M; Drommer W; Reichl U; Boge A
    Dtsch Tierarztl Wochenschr; 1997 Jun; 104(6):196-202. PubMed ID: 9303851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of rabbits with a bovine herpesvirus type 1 subunit vaccine: adjuvant effect of ISCOMs.
    Trudel M; Nadon F; Seguin C; Boulay G; Lussier G
    Vaccine; 1987 Sep; 5(3):239-43. PubMed ID: 2823496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory response and antigen localization following immunization with influenza virus ISCOMs.
    Watson DL; Lövgren K; Watson NA; Fossum C; Morein B; Höglund S
    Inflammation; 1989 Dec; 13(6):641-9. PubMed ID: 2613292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine distemper virus (CDV) immune-stimulating complexes (Iscoms), but not measles virus iscoms, protect dogs against CDV infection.
    De Vries P; Uytdehaag FG; Osterhaus AD
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2071-83. PubMed ID: 3404123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of glycoprotein gII ISCOMs subunit vaccine for pseudorabies in pig.
    Tsuda T; Sugimura T; Murakami Y
    Vaccine; 1991 Sep; 9(9):648-52. PubMed ID: 1659053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
    Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
    Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier.
    Lövgren K; Lindmark J; Pipkorn R; Morein B
    J Immunol Methods; 1987 Apr; 98(1):137-43. PubMed ID: 2435808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
    Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
    Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of immunostimulating complexes (ISCOMs) of Japanese encephalitis virus.
    Yeolekar LR; Banerjee K
    Vaccine; 1996 Nov; 14(16):1553-9. PubMed ID: 9014299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The requirement of lipids for the formation of immunostimulating complexes (iscoms).
    Lövgren K; Morein B
    Biotechnol Appl Biochem; 1988 Apr; 10(2):161-72. PubMed ID: 2838046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
    Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
    Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method.
    Demana PH; Davies NM; Vosgerau U; Rades T
    Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.